Trials / Unknown
UnknownNCT03018821
The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B
Efficacy Comparison Between Two Kind of Chinese Herbal Formulas on Traditional Chinese Medicine Syndromes Among Chronic Hepatitis Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Xi'an Traditional Medicine Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Although the incidence of Hepatitis B has been decreased a lot recently years, there are still quite a few chronic hepatitis B patients in China. The anti-virus drugs of western medicine such as Entecavir and Tenofovir have been proved effective on decreasing the serum hepatitis B virus (HBV) level, on the other hand, Chinese materia medica showed effective on TCM syndromes of chronic hepatitis B (CHB) such as hypochondriac pain, jaundice and abdominal mass. Besides, the hepatic fibrosis could be delayed after the appropriate treatment of TCM. This study is a multicenter, randomized, open label, parallel group clinical trial to evaluate the efficacy of two different traditional Chinese medicine (TCM) herbal treatment on chronic hepatitis B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Standard - Yinchengao Decoction plus Ganlu Detoxification Pill | Yinchengao Decoction plus Ganlu Detoxification Pill is one Chinese Medicine Formula for the TCM syndrome: Damp-heat blocking middle jiao. |
| DRUG | Entecavir or Tenofovir | Western drug for anti-HBV such as Entecavir and Tenofovir |
| DRUG | Standard - Ge Xia Zhu Yu Decoction | Ge Xia Zhu Yu Decoction is one Chinese Medicine Formula for the TCM syndrome: internal blood stasis. |
| DRUG | Advanced - Supplemented Taohong Huazhuo Decoction | Supplemented Taohong Huazhuo Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Damp-heat blocking middle jiao. |
| DRUG | Standard - Chaihu Shugan San | Chaihu Shugan San is one Chinese Medicine Formula for the TCM syndrome: Liver depression and qi stagnation. |
| DRUG | Advanced - Soothe the liver and regulate qi Decoction | Soothe the liver and regulate qi Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Liver depression and qi stagnation. |
| DRUG | Standard - Xiaoyao powder | Xiaoyao powder is one Chinese Medicine Formula for the TCM syndrome: Stagnation of liver qi and spleen deficiency. |
| DRUG | Advanced - Supplemented Ganbi Decoction | Supplemented Ganbi Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Stagnation of liver qi and spleen deficiency. |
| DRUG | Standard - Yiguan Decoction | Yiguan Decoction is one Chinese Medicine Formula for the TCM syndrome: Yin deficiency of liver and kidney. |
| DRUG | Advanced - Supplemented Zimu Dan | Supplemented Zimu Dan is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Yin deficiency of liver and kidney. |
| DRUG | Standard - Fuzilizhong Decoction plus Jinkui Shenqi Bolus | Fuzilizhong Decoction plus Jinkui Shenqi Bolus is one Chinese Medicine Formula for the TCM syndrome: Yang deficiency of spleen and kidney. |
| DRUG | Advanced - Guifu Erxian Decoction | Guifu Erxian Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Yang deficiency of spleen and kidney. |
| DRUG | Advanced - Supplemented Ganji Decoction | Supplemented Ganji Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: internal blood stasis. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-10-01
- Completion
- 2017-12-01
- First posted
- 2017-01-12
- Last updated
- 2017-01-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03018821. Inclusion in this directory is not an endorsement.